These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 35723978)
1. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation. Nguyen HL; Thai NQ; Nguyen PH; Li MS J Phys Chem B; 2022 Jun; 126(25):4669-4678. PubMed ID: 35723978 [TBL] [Abstract][Full Text] [Related]
2. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence. Kumar R; Murugan NA; Srivastava V Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828 [TBL] [Abstract][Full Text] [Related]
3. Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody. Kumar V; Shefrin S; Sundar D J Struct Biol; 2024 Jun; 216(2):108087. PubMed ID: 38494148 [TBL] [Abstract][Full Text] [Related]
4. Investigating the role of glycans in Omicron sub-lineages XBB.1.5 and XBB.1.16 binding to host receptor using molecular dynamics and binding free energy calculations. Singh JK; Singh J; Srivastava SK J Comput Aided Mol Des; 2023 Nov; 37(11):551-563. PubMed ID: 37542610 [TBL] [Abstract][Full Text] [Related]
5. Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant. Jawad B; Adhikari P; Podgornik R; Ching WY J Phys Chem Lett; 2022 May; 13(17):3915-3921. PubMed ID: 35481766 [TBL] [Abstract][Full Text] [Related]
6. Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant. Wang WB; Ma YB; Lei ZH; Zhang XF; Li J; Li SS; Dong ZY; Liang Y; Li QM; Su JG J Mol Graph Model; 2023 Nov; 124():108540. PubMed ID: 37352723 [TBL] [Abstract][Full Text] [Related]
7. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants. da Costa CHS; de Freitas CAB; Alves CN; Lameira J Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778 [TBL] [Abstract][Full Text] [Related]
8. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment. Kumar S; Karuppanan K; Subramaniam G J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610 [TBL] [Abstract][Full Text] [Related]
9. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2. Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508 [TBL] [Abstract][Full Text] [Related]
10. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies. Shah M; Woo HG Front Immunol; 2021; 12():830527. PubMed ID: 35140714 [TBL] [Abstract][Full Text] [Related]
11. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations. Wu J; Zhang HX; Zhang J Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957 [TBL] [Abstract][Full Text] [Related]
12. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2. Fazekas Z; Menyhárd DK; Perczel A J Chem Inf Model; 2022 Aug; 62(16):3844-3853. PubMed ID: 35849759 [TBL] [Abstract][Full Text] [Related]
13. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 omicron RBD forms a weaker binding affinity to hACE2 compared to Delta RBD in Le HT; Tran LH; Phung HTT J Biomol Struct Dyn; 2024 May; 42(8):4087-4096. PubMed ID: 37345564 [TBL] [Abstract][Full Text] [Related]
15. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach. Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791 [No Abstract] [Full Text] [Related]
16. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor. Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346 [TBL] [Abstract][Full Text] [Related]
17. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods. Ebrahimi M; Karami L; Alijanianzadeh M Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285 [TBL] [Abstract][Full Text] [Related]
18. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells. Singh AV; Kayal A; Malik A; Maharjan RS; Dietrich P; Thissen A; Siewert K; Curato C; Pande K; Prahlad D; Kulkarni N; Laux P; Luch A Langmuir; 2022 Jul; 38(26):7976-7988. PubMed ID: 35736838 [TBL] [Abstract][Full Text] [Related]
19. Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness Zhang Z; Zhang J; Wang J Front Public Health; 2022; 10():952916. PubMed ID: 36091499 [TBL] [Abstract][Full Text] [Related]
20. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2. Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]